Newsroom | 12728 results
Sorted by: Latest
-
EvoEndo® Surpasses 3,000 Sedation-Free Transnasal Endoscopy Procedures Nationwide
CHICAGO--(BUSINESS WIRE)--EvoEndo®, Inc. (EvoEndo) today announced that practitioners have now completed more than 3,000 sedation-free transnasal endoscopy (TNE) procedures using the EvoEndo Endoscopy System, as implementation expands to more than 70 locations nationwide. “Reaching 3,000 cases is an important milestone, but what matters most is what it represents for patients, families, and physicians,” said Jonathan Hartmann, CEO of EvoEndo. “Every case reflects greater access to sedation-free...
-
SurGenTec® Secures FDA Clearance for ION-L™ - Lumbar Navigation Compatible
BOCA RATON, Fla.--(BUSINESS WIRE)--SurGenTec®, a medical device company focused on advancing treatment options for orthopedic and spine surgery, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for its ION-L™ navigation instruments for use with the ION-L™ Lumbar Facet Fixation System. The system is engineered for compatibility with Medtronic's StealthStation™ navigation platform, enabling enhanced precision during posterior lumbar facet fusion proced...
-
EndoQuest Robotics Announces Completion of Enrollment in the PARADIGM Trial
HOUSTON--(BUSINESS WIRE)--EndoQuest Robotics, Inc., a pioneering leader in endoluminal robotic surgical technology, today announced that enrollment in its pivotal multicenter investigational device exemption (IDE) clinical study, the PARADIGM Trial (Prospective Assessment of a Robotic Assisted Device in Gastrointestinal Medicine), has concluded after the completion of 50 robotic endoscopic submucosal dissection (ESD) procedures across 49 subjects (Clinicaltrials.gov). Preliminary results for th...
-
Edwards Lifesciences Reports Second Quarter Results
IRVINE, Calif.--(BUSINESS WIRE)--Edwards Lifesciences (NYSE: EW) today reported financial results for the quarter ended June 30, 2026. Highlights Q2 sales grew 13.6% to $1.74 billion1, constant currency2 sales grew 12.5% Q2 TAVR sales grew 11.3% to $1.26 billion1; constant currency2 sales grew 10.5% Q2 TMTT sales were $195.9 million1,3, driven by portfolio of repair and replacement therapies Q2 EPS of $0.421; adjusted2 EPS of $0.781 Recent clinical data at New York Valves reinforce best-in-clas...
-
Tenet Reports Strong Second Quarter 2026 Results; Raises 2026 Financial Outlook
DALLAS--(BUSINESS WIRE)--Tenet Healthcare Corporation (Tenet) (NYSE: THC) today announced its results for the quarter ended June 30, 2026. "Strong same-store revenue growth and effective expense management drove our fundamental outperformance in the second quarter of 2026 compared to our original assumptions," said Saum Sutaria, M.D., Chairman and Chief Executive Officer of Tenet. "We are actively navigating current industry dynamics through excellent operational execution, investments in innov...
-
AtriCure Reports Second Quarter 2026 Financial Results
MASON, Ohio--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management, today announced second quarter 2026 financial results. “Our team delivered healthy growth and a significant step up in profitability in the second quarter,” said Michael Carrel, President and Chief Executive Officer. “Our innovative technologies continue to prove their valu...
-
OneLegacy Partners with OrganOx to Transform Liver Transplantation, Offering Advanced Medical Solutions to Transplant Centers in Southern California
LOS ANGELES--(BUSINESS WIRE)--OneLegacy is offering advanced medical solutions to Southern California transplant centers through liver perfusion with the OrganOx metra®. Normothermic machine perfusion (NMP) can save more lives by increasing the number of liver transplants by 20% to 30% and reducing the transplant wait list. Earlier this week, OneLegacy hosted an educational symposium at its Azusa Transplant Recovery Center, bringing together transplant centers and organ procurement organization...
-
UF Health Kidney and Liver Transplant Programs Once Again Rank Among Nation's Best
GAINESVILLE, Fla.--(BUSINESS WIRE)--New data from the Scientific Registry of Transplant Recipients once again place UF Health’s abdominal transplant programs among the best in the nation. The adult kidney transplant program has joined the liver transplant program as a leader in Florida and across the United States, achieving the nation’s highest one-year graft survival rate. Released twice annually, SRTR reports provide patients and health care professionals with important information about tra...
-
Feinstein Institutes Researchers Honored With Seven Prestigious Awards at the 2026 Shock Society Annual Conference
MANHASSET, N.Y.--(BUSINESS WIRE)--Responsible for millions of deaths worldwide, sepsis, a life-threatening condition where the body’s immune system spirals out of control, demands relentless and innovative research to advance understanding and deliver life-saving therapies. For their dedication to sepsis research, investigators from Northwell Health’s Feinstein Institutes for Medical Research were the recipients of seven prestigious awards at the 2026 Shock Society Annual Conference last month....
-
Proximie Builds the Next Generation of Surgical Intelligence
SAN DIEGO--(BUSINESS WIRE)--Proximie, the operating system for intelligent operating rooms (ORs), has signed a multi-year partnership agreement with UC San Diego Health, one of the United States’ leading academic medical centers, to deploy its Intelligence Suite in 44 ORs and procedure rooms across four hospital sites – marking one of Proximie’s most extensive deployments in the Americas. The collaboration establishes UC San Diego Health as a flagship clinical, technical, and operational co-dev...